Stocks
Otonomy, Inc.OTIC
NASDAQHealthcareBiotechnology$0.01-92.64%
A clinical-stage biopharmaceutical company focused on developing treatments for disorders of the inner ear, including hearing loss, tinnitus, and Ménière’s disease. Its pipeline centered on drug candidates delivered directly to the ear using localized formulations designed to improve efficacy while ...
Market Cap: $052W Range: $0.01 – $2.51
Congressional Interest in Otonomy, Inc. (OTIC)
1 member of Congress has disclosed 2 trades in Otonomy, Inc. (OTIC), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
1
Sells
1
Who in Congress Is Trading OTIC?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-10-09 | Roger W. Marshall | sell | $1K – $15K |
| 2017-05-01 | Roger W. Marshall | buy | $1K – $15K |